𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Time to Prostate-Specific Antigen Nadir After Androgen Suppression Therapy for Postoperative or Postradiation PSA Failure and Risk of Prostate Cancer-Specific Mortality

✍ Scribed by Christine S. Chung; Ming-Hui Chen; Jennifer Cullen; David McLeod; Peter Carroll; Anthony V. D’Amico

Book ID
116948719
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
291 KB
Volume
71
Category
Article
ISSN
0090-4295

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Time to an undetectable prostate-specifi
Time to an undetectable prostate-specific antigen (PSA) after androgen suppression therapy for postoperative or postradiation PSA recurrence and prostate cancer-specific mortality
✍ Anthony V. D'Amico; David G. McLeod; Peter R. Carroll; Jennifer Cullen; Ming-Hui 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB

## Abstract ## BACKGROUND For men receiving androgen‐suppression therapy (AST) for a rising postoperative or postradiation prostate‐specific antigen (PSA) recurrence, whether the time to an undetectable (u) PSA was significantly associated with prostate cancer‐specific mortality (PCSM) was evaluat

Influence of body mass index on prostate
Influence of body mass index on prostate-specific antigen failure after androgen suppression and radiation therapy for localized prostate cancer
✍ Jason A. Efstathiou; Ming-Hui Chen; Andrew A. Renshaw; Marian J. Loffredo; Antho 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 1 views

## Abstract ## BACKGROUND Increasing body mass index (BMI) is associated with shorter time to prostate‐specific antigen (PSA) failure after radical prostatectomy. Whether BMI is associated with time to PSA failure was investigated in men treated with androgen suppression therapy (AST) and radiatio